| Identification | Back Directory | [Name]
Propanamide, 3,3'-[[2-[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-2-amino-1,3-propanediyl]bis(oxy)]bis[N-[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]- | [CAS]
1426160-58-8 | [Synonyms]
ASGPR ligand-1
Propanamide, 3,3'-[[2-[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-2-amino-1,3-propanediyl]bis(oxy)]bis[N-[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]- | [Molecular Formula]
C61H110N10O27 | [MOL File]
1426160-58-8.mol | [Molecular Weight]
1415.58 |
| Hazard Information | Back Directory | [Uses]
ASGPR ligand-1 is an asialoglycoprotein receptor (ASGPR) ligand compound. ASGPR ligand-1 can be used for kinds of diseases research[1]. | [References]
[1] Martin Allan, et al. Targeted plasma protein degradation. Patent. WO2021156792 |
|
|